Identification of Aim2 as a sensor for DNA vaccines

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 630-636

  Suschak, John J ^a   Wang, Shixia ^a   Fitzgerald, Katherine A ^a   Lu, Shan ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIM2 PROTEIN; ALPHA INTERFERON; BETA INTERFERON; DNA VACCINE; IMMUNOGLOBULIN G; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG; AIM2 PROTEIN, MOUSE; DNA BINDING PROTEIN; IL1B PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DNA IMMUNIZATION; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREGULATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYROPTOSIS; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-18; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; VACCINES, DNA;

EID: 84920374073     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402530     Document Type: Article

References (38)

1. Wang, R., J. Epstein, F. M. Baraceros, E. J. Gorak, Y. Charoenvit, D. J. Carucci, R. C. Hedstrom, N. Rahardjo, T. Gay, P. Hobart, et al. 2001. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNAvaccine. Proc. Natl. Acad. Sci. USA 98: 10817-10822.
2. Wang, S., A. Hackett, N. Jia, C. Zhang, L. Zhang, C. Parker, A. Zhou, J. Li, W. C. Cao, Z. Huang, et al. 2011. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses. PLoS ONE 6: e28757.
3. Wang, S., J. S. Kennedy, K. West, D. C. Montefiori, S. Coley, J. Lawrence, S. Shen, S. Green, A. L. Rothman, F. A. Ennis, et al. 2008. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 26: 1098-1110.
4. Wang, S., C. Zhang, L. Zhang, J. Li, Z. Huang, and S. Lu. 2008. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26: 2100-2110.
5. Yang, Z. Y., W. P. Kong, Y. Huang, A. Roberts, B. R. Murphy, K. Subbarao, and G. J. Nabel. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428: 561-564.
6. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152-154.
7. Kennedy, J. S., M. Co, S. Green, K. Longtine, J. Longtine, M. A. O'Neill, J. P. Adams, A. L. Rothman, Q. Yu, R. Johnson-Leva, et al. 2008. The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers. Vaccine 26: 4420-4424.
8. Khurana, S., J. Wu, M. Dimitrova, L. R. King, J. Manischewitz, B. S. Graham, J. E. Ledgerwood, and H. Golding. 2013. DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. J. Infect. Dis. 208: 413-417.
9. Ledgerwood, J. E., Z. Hu, I. J. Gordon, G. Yamshchikov, M. E. Enama, S. Plummer, R. Bailer, M. B. Pearce, T. M. Tumpey, R. A. Koup, et al; VRC 304 and VRC 305 Study Teams. 2012. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans. Clin. Vaccine Immunol. 19: 1792-1797.
10. Ledgerwood, J. E., C. J. Wei, Z. Hu, I. J. Gordon, M. E. Enama, C. S. Hendel, P. M. McTamney, M. B. Pearce, H. M. Yassine, J. C. Boyington, et al; VRC 306 Study Team. 2011. DNA priming and influenza vaccine immunogenicity: Two phase 1 open label randomised clinical trials. Lancet Infect. Dis. 11: 916-924.
11. Li, W., S. Wang, and S. Lu. 2014. Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. Vaccines 2: 36-48.
12. Hollister, K., Y. Chen, S. Wang, H. Wu, A. Mondal, N. Clegg, S. Lu, and A. Dent. 2014. The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination. Hum. Vaccin. Immunother. 10: 7.
13. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
14. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
15. Wilkins, C., and M. Gale Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22: 41-47.
16. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
17. Spies, B., H. Hochrein, M. Vabulas, K. Huster, D. H. Busch, F. Schmitz, A. Heit, and H. Wagner. 2003. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 171: 5908-5912.
18. Babiuk, S., N. Mookherjee, R. Pontarollo, P. Griebel, S. van Drunen Littel-van den Hurk, R. Hecker, and L. Babiuk. 2004. TLR9-/- And TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113: 114-120.
19. Ishii, K. J., T. Kawagoe, S. Koyama, K. Matsui, H. Kumar, T. Kawai, S. Uematsu, O. Takeuchi, F. Takeshita, C. Coban, and S. Akira. 2008. TANKbinding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451: 725-729.
20. Ishikawa, H., Z. Ma, and G. N. Barber. 2009. STING regulates intracellular DNAmediated, type I interferon-dependent innate immunity. Nature 461: 788-792.
21. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11: 997-1004.
22. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
23. Li, X. D., J. Wu, D. Gao, H. Wang, L. Sun, and Z. J. Chen. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341: 1390-1394.
24. Ishii, K. J., C. Coban, H. Kato, K. Takahashi, Y. Torii, F. Takeshita, H. Ludwig, G. Sutter, K. Suzuki, H. Hemmi, et al. 2006. A Toll-like receptorindependent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7: 40-48.
25. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell 10: 417-426.
26. Rathinam, V. A., Z. Jiang, S. N. Waggoner, S. Sharma, L. E. Cole, L. Waggoner, S. K. Vanaja, B. G. Monks, S. Ganesan, E. Latz, et al. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11: 395-402.
27. Kalantari, P., R. B. DeOliveira, J. Chan, Y. Corbett, V. Rathinam, A. Stutz, E. Latz, R. T. Gazzinelli, D. T. Golenbock, and K. A. Fitzgerald. 2014. Dual engagement of the NLRP3 and AIM2 inflammasomes by plasmodium-derived hemozoin and DNA during malaria. Cell Reports 6: 196-210.
28. Hanamsagar, R., A. Aldrich, and T. Kielian. 2014. Critical role for the AIM2 inflammasome during acute CNS bacterial infection. J. Neurochem. 129: 704-711.
29. Wang, S., J. Taaffe, C. Parker, A. Solórzano, H. Cao, A. García-Sastre, and S. Lu. 2006. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J. Virol. 80: 11628-11637.
30. Wang, S., C. Parker, J. Taaffe, A. Solórzano, A. García-Sastre, and S. Lu. 2008. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26: 3626-3633.
31. Suguitan, A. L. Jr., X. Cheng, W. Wang, S. Wang, H. Jin, and S. Lu. 2011. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. PLoS ONE 6: e21942.
32. Zhang, L., N. Jia, J. Li, Y. Han, W. Cao, S. Wang, Z. Huang, and S. Lu. 2014. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses. Hum. Vaccin. Immunother. 10: 10.
33. Almansour, I., H. Chen, S. Wang, and S. Lu. 2013. Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years. Hum. Vaccin. Immunother. 9: 2049-2059.
34. Baccala, R., K. Hoebe, D. H. Kono, B. Beutler, and A. N. Theofilopoulos. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13: 543-551.
35. Okabe, Y., K. Kawane, S. Akira, T. Taniguchi, and S. Nagata. 2005. Tolllike receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202: 1333- 1339.
36. Stetson, D. B., and R. Medzhitov. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103.
37. Eto, D., C. Lao, D. DiToro, B. Barnett, T. C. Escobar, R. Kageyama, I. Yusuf, and S. Crotty. 2011. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6: e17739.
38. Ishii, K. J., and S. Akira. 2006. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27: 525-532.